ScholarIQanswers from OpenAlex
Trial of Tocilizumab in Giant-Cell Arteritis
PaperCitations, authors & open-access status
Trial of Tocilizumab in Giant-Cell Arteritis is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Trial of Tocilizumab in Giant-Cell Arteritis have?
ScholarIQcitation count
Trial of Tocilizumab in Giant-Cell Arteritis has 1,390 citations in the OpenAlex counts ScholarIQ stores.
When was Trial of Tocilizumab in Giant-Cell Arteritis published?
ScholarIQyear
Trial of Tocilizumab in Giant-Cell Arteritis has 2017 year in the ScholarIQ index.
What is the open-access status of Trial of Tocilizumab in Giant-Cell Arteritis?
ScholarIQoa status
Trial of Tocilizumab in Giant-Cell Arteritis has bronze oa status in the ScholarIQ index.
What is the DOI of Trial of Tocilizumab in Giant-Cell Arteritis?
ScholarIQdoi
The DOI for Trial of Tocilizumab in Giant-Cell Arteritis is on the source record.
What is the PMID of Trial of Tocilizumab in Giant-Cell Arteritis?
ScholarIQpmid
The PMID for Trial of Tocilizumab in Giant-Cell Arteritis is on the source record.
What is the OpenAlex record for Trial of Tocilizumab in Giant-Cell Arteritis?
ScholarIQopenalex
The OpenAlex for Trial of Tocilizumab in Giant-Cell Arteritis is on the source record.